A Guide to Understanding and Managing This Inherited Metabolic Condition
This template doesn't have any video presentations yet. Be the first to create one!
Record yourself for just 2 minutes to generate a professional AI video for your patients.
Get StartedBe the first to create a video version of this content featuring your own AI avatar - just submit a quick 2-minute recording.
Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) is an inherited metabolic disorder that affects how the body breaks down fats for energy.
MCADD occurs due to mutations in the ACADM gene, which provides instructions for making an enzyme called medium-chain acyl-CoA dehydrogenase. This enzyme is essential for:
Symptoms typically appear when the body needs to break down fat for energy, such as during:
With proper management, individuals with MCADD can lead normal, healthy lives. Early diagnosis and consistent preventive measures are key to success.
Contact healthcare providers immediately if:
Be the first to create a video version of this content featuring your own AI avatar - just submit a quick 2-minute recording.